These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19167249)

  • 1. The shaping of T cell receptor recognition by self-tolerance.
    Gras S; Burrows SR; Kjer-Nielsen L; Clements CS; Liu YC; Sullivan LC; Bell MJ; Brooks AG; Purcell AW; McCluskey J; Rossjohn J
    Immunity; 2009 Feb; 30(2):193-203. PubMed ID: 19167249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the structure of the LC13 TCR/HLA-B8-EBV peptide complex with molecular dynamics simulations.
    Stavrakoudis A
    Cell Biochem Biophys; 2011 Jul; 60(3):283-95. PubMed ID: 21253892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structural basis for varied αβ TCR usage against an immunodominant EBV antigen restricted to a HLA-B8 molecule.
    Gras S; Wilmann PG; Chen Z; Halim H; Liu YC; Kjer-Nielsen L; Purcell AW; Burrows SR; McCluskey J; Rossjohn J
    J Immunol; 2012 Jan; 188(1):311-21. PubMed ID: 22140258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire.
    Burrows SR; Silins SL; Cross SM; Peh CA; Rischmueller M; Burrows JM; Elliott SL; McCluskey J
    Eur J Immunol; 1997 Jan; 27(1):178-82. PubMed ID: 9022015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
    Burrows SR; Silins SL; Moss DJ; Khanna R; Misko IS; Argaet VP
    J Exp Med; 1995 Dec; 182(6):1703-15. PubMed ID: 7500015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell allorecognition via molecular mimicry.
    Macdonald WA; Chen Z; Gras S; Archbold JK; Tynan FE; Clements CS; Bharadwaj M; Kjer-Nielsen L; Saunders PM; Wilce MC; Crawford F; Stadinsky B; Jackson D; Brooks AG; Purcell AW; Kappler JW; Burrows SR; Rossjohn J; McCluskey J
    Immunity; 2009 Dec; 31(6):897-908. PubMed ID: 20064448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire.
    D'Orsogna LJ; Amir AL; Zoet YM; van der Meer-Prins PM; van der Slik AR; Kester MG; Heemskerk MH; Doxiadis II; Roelen DL; Claas FH
    Tissue Antigens; 2009 Oct; 74(4):290-7. PubMed ID: 19624615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules.
    Hansen BE; Rasmussen AH; Jakobsen BK; Ryder LP; Svejgaard A
    Tissue Antigens; 2007 Jul; 70(1):42-52. PubMed ID: 17559580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization.
    Kjer-Nielsen L; Clements CS; Brooks AG; Purcell AW; Fontes MR; McCluskey J; Rossjohn J
    J Immunol; 2002 Nov; 169(9):5153-60. PubMed ID: 12391232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection.
    Ely LK; Green KJ; Beddoe T; Clements CS; Miles JJ; Bottomley SP; Zernich D; Kjer-Nielsen L; Purcell AW; McCluskey J; Rossjohn J; Burrows SR
    J Immunol; 2005 May; 174(9):5593-601. PubMed ID: 15843558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deflecting a canonical antiviral T cell response.
    Malissen B
    Immunity; 2009 Feb; 30(2):169-71. PubMed ID: 19239897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule.
    Tynan FE; Reid HH; Kjer-Nielsen L; Miles JJ; Wilce MC; Kostenko L; Borg NA; Williamson NA; Beddoe T; Purcell AW; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2007 Mar; 8(3):268-76. PubMed ID: 17259989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large scale characterization of the LC13 TCR and HLA-B8 structural landscape in reaction to 172 altered peptide ligands: a molecular dynamics simulation study.
    Knapp B; Dunbar J; Deane CM
    PLoS Comput Biol; 2014 Aug; 10(8):e1003748. PubMed ID: 25101830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants.
    Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Baxter TK; Clemens JR; Armstrong KM; Turner RV; Damirjian M; Biddison WE; Baker BM
    J Mol Biol; 2005 Oct; 353(3):556-73. PubMed ID: 16197958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition.
    Borg NA; Ely LK; Beddoe T; Macdonald WA; Reid HH; Clements CS; Purcell AW; Kjer-Nielsen L; Miles JJ; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2005 Feb; 6(2):171-80. PubMed ID: 15640805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.
    Gras S; Saulquin X; Reiser JB; Debeaupuis E; Echasserieau K; Kissenpfennig A; Legoux F; Chouquet A; Le Gorrec M; Machillot P; Neveu B; Thielens N; Malissen B; Bonneville M; Housset D
    J Immunol; 2009 Jul; 183(1):430-7. PubMed ID: 19542454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The production, purification and crystallization of a soluble heterodimeric form of a highly selected T-cell receptor in its unliganded and liganded state.
    Clements CS; Kjer-Nielsen L; MacDonald WA; Brooks AG; Purcell AW; McCluskey J; Rossjohn J
    Acta Crystallogr D Biol Crystallogr; 2002 Dec; 58(Pt 12):2131-4. PubMed ID: 12454477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymic microenvironments for T-cell repertoire formation.
    Nitta T; Murata S; Ueno T; Tanaka K; Takahama Y
    Adv Immunol; 2008; 99():59-94. PubMed ID: 19117532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry.
    Sami M; Rizkallah PJ; Dunn S; Molloy P; Moysey R; Vuidepot A; Baston E; Todorov P; Li Y; Gao F; Boulter JM; Jakobsen BK
    Protein Eng Des Sel; 2007 Aug; 20(8):397-403. PubMed ID: 17644531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition.
    Ressing ME; van Leeuwen D; Verreck FA; Gomez R; Heemskerk B; Toebes M; Mullen MM; Jardetzky TS; Longnecker R; Schilham MW; Ottenhoff TH; Neefjes J; Schumacher TN; Hutt-Fletcher LM; Wiertz EJ
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11583-8. PubMed ID: 14504389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.